Synthetic Cell Mimics Improve Flow Cytometry Controls

Amsbio has launched a range of synthetic cell mimic products that eliminate the variability, fragility, and operational inefficiency inherent in traditional flow cytometry biological and polystyrene bead controls.

Researchers in pharmaceutical companies, biotechnology firms, CRO’s, clinical diagnostics and academic centres have long sought access to mass-produced cell mimics that contain rare biomarkers and are stable over the long term for the development of targeted therapies.

Benefitting from unmatched lot-to-lot consistency with coefficients of variation as low as 0.1% these new synthetic cell-mimic controls enable researchers to achieve reproducible results across multiple sites and instruments. This consistency is a critical requirement for clinical trials, cell therapy manufacturing, and rapid, successful regulatory submissions.

For laboratory teams running flow cytometry assays across instruments, operators, and sites, Amsbio can now offer cell-mimic controls that deliver biology-like behaviour without donor PBMCs’ variability, biohazardous materials safety burden, or cell lines maintenance overhead. This helps researchers standardize workflows, tighten assay performance, and reduce bridging studies. Offering extended shelf life with no maintenance required – synthetic cell mimics from Amsbio are fully customizable with biomarkers, proteins, and fluorescence making them perfect for any need.

This article has been republished from external sources. Note: Material may have been edited for clarity, length, or style. For more information, please contact the cited source.